ArticleJournal of cheminformatics2020
Evaluation of deep and shallow learning methods in chemogenomics for the prediction of drugs specificity.
Article in Journal of cheminformatics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Predicting small molecule-RNA interactions without RNA tertiary structures.Nature biotechnology · 2026Article
- Deep learning decodes species-specific codon usage signatures in Brassica from coding sequences.Scientific reports · 2025Article
- QSPRpred: a Flexible Open-Source Quantitative Structure-Property Relationship Modelling Tool.Journal of cheminformatics · 2024Article
- Drug-Target Interactions Prediction at Scale: The Komet Algorithm with the LCIdb Dataset.Journal of chemical information and modeling · 2024Article
- Combination therapy synergism prediction for virus treatment using machine learning models.PloS one · 2024Article
- An overview of recent advances and challenges in predicting compound-protein interaction (CPI).Medical review (2021) · 2023Review
- Transfer learning for drug-target interaction prediction.Bioinformatics (Oxford, England) · 2023Article
- DEDTI versus IEDTI: efficient and predictive models of drug-target interactions.Scientific reports · 2023Article
- A review of SARS-CoV-2 drug repurposing: databases and machine learning models.Frontiers in pharmacology · 2023Review
- Off-targetP ML: an open source machine learning framework for off-target panel safety assessment of small molecules.Journal of cheminformatics · 2022Article
- Sequence-based prediction of protein binding regions and drug-target interactions.Journal of cheminformatics · 2022Article
- A Clinical Decision Web to Predict ICU Admission or Death for Patients Hospitalised with COVID-19 Using Machine Learning Algorithms.International journal of environmental research and public health · 2021Article
- Pretraining model for biological sequence data.Briefings in functional genomics · 2021Review
- Drug Target Identification with Machine Learning: How to Choose Negative Examples.International journal of molecular sciences · 2021Article
- Biological network analysis with deep learning.Briefings in bioinformatics · 2021Review
- Learning the Regulatory Code of Gene Expression.Frontiers in molecular biosciences · 2021Review
- Chagas Disease: Perspectives on the Past and Present and Challenges in Drug Discovery.Molecules (Basel, Switzerland) · 2020Review
- Deep Docking: A Deep Learning Platform for Augmentation of Structure Based Drug Discovery.ACS central science · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Chemogenomics, also called proteochemometrics, covers a range of computational methods that can be used to predict protein-ligand interactions at large scales in the protein and chemical spaces. They differ from more classical ligand-based methods (also called QSAR) that predict ligands for a given protein receptor. In the context of drug discovery process, chemogenomics allows to tackle the question of predicting off-target proteins for drug candidates, one of the main causes of undesirable side-effects and failure within drugs development processes. The present study compares shallow and deep machine-learning approaches for chemogenomics, and explores data augmentation techniques for deep learning algorithms in chemogenomics. Shallow machine-learning algorithms rely on expert-based chemical and protein descriptors, while recent developments in deep learning algorithms enable to learn abstract numerical representations of molecular graphs and protein sequences, in order to optimise the performance of the prediction task. We first propose a formulation of chemogenomics with deep learning, called the chemogenomic neural network (CN), as a feed-forward neural network taking as input the combination of molecule and protein representations learnt by molecular graph and protein sequence encoders. We show that, on large datasets, the deep learning CN model outperforms state-of-the-art shallow methods, and competes with deep methods with expert-based descriptors. However, on small datasets, shallow methods present better prediction performance than deep learning methods. Then, we evaluate data augmentation techniques, namely multi-view and transfer learning, to improve the prediction performance of the chemogenomic neural network. We conclude that a promising research direction is to integrate heterogeneous sources of data such as auxiliary tasks for which large datasets are available, or independently, multiple molecule and protein attribute views.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.